- Home
- APRE vs MRM Comparison
APRE vs MRM Comparison
Compare APRE & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- MRM
- Stock Information
- Founded
- APRE 2006
- MRM 2000
- Country
- APRE United States
- MRM Japan
- Employees
- APRE N/A
- MRM N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- MRM Other Consumer Services
- Sector
- APRE Health Care
- MRM Consumer Discretionary
- Exchange
- APRE Nasdaq
- MRM Nasdaq
- Market Cap
- APRE 9.4M
- MRM 10.4M
- IPO Year
- APRE 2019
- MRM 2020
- Fundamental
- Price
- APRE $1.69
- MRM $2.12
- Analyst Decision
- APRE Strong Buy
- MRM
- Analyst Count
- APRE 1
- MRM 0
- Target Price
- APRE $20.00
- MRM N/A
- AVG Volume (30 Days)
- APRE 60.0K
- MRM 6.7M
- Earning Date
- APRE 08-12-2025
- MRM 05-20-2025
- Dividend Yield
- APRE N/A
- MRM N/A
- EPS Growth
- APRE N/A
- MRM 27.65
- EPS
- APRE N/A
- MRM 0.18
- Revenue
- APRE $841,012.00
- MRM $52,786,758.00
- Revenue This Year
- APRE N/A
- MRM N/A
- Revenue Next Year
- APRE N/A
- MRM N/A
- P/E Ratio
- APRE N/A
- MRM $11.69
- Revenue Growth
- APRE N/A
- MRM 21.55
- 52 Week Low
- APRE $1.41
- MRM $0.34
- 52 Week High
- APRE $5.01
- MRM $8.39
- Technical
- Relative Strength Index (RSI)
- APRE 46.79
- MRM 60.78
- Support Level
- APRE $1.66
- MRM $1.90
- Resistance Level
- APRE $1.79
- MRM $3.53
- Average True Range (ATR)
- APRE 0.14
- MRM 0.40
- MACD
- APRE -0.01
- MRM 0.09
- Stochastic Oscillator
- APRE 38.89
- MRM 41.93
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.